(Q40233581)

18 September 2017

title

Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation (English)

1 reference

18 September 2017

1 reference

C Cai

1

1 reference

18 September 2017

S-Y Chen

2

1 reference

18 September 2017

Z Zheng

3

1 reference

18 September 2017

J Omwancha

4

1 reference

18 September 2017

M-F Lin

5

1 reference

18 September 2017

S P Balk

6

1 reference

18 September 2017

L Shemshedini

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

11 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

26

1 reference

18 September 2017

issue

11

1 reference

18 September 2017

page(s)

1606-1615

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209956

18 September 2017

exact match

0 references

cites work

Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The bradykinin/soluble guanylate cyclase signaling pathway is impaired in androgen-independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The endocrinology and developmental biology of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Mutation of the androgen receptor causes oncogenic transformation of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The biology of hormone refractory prostate cancer. Why does it develop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Regulation of nitric oxide and soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Androgens and androgen receptor in prostate and ovarian malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Androgen-regulated gene expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

7 January 2021

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

7 January 2021

Antagonistic effect of androgen on prostatic cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

7 January 2021

Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

7 January 2021

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209956

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209956

1 reference

Dimensions Publication ID

18 September 2017

1050180456

0 references

1 reference